ERYTECH provides financial update for Q2 2013 Post author:admERY Post published:July 18, 2013 Post category:Newsroom ERYTECH announced today its cash position and its revenues for the second quarter of 2013. You Might Also Like ERYTECH positions its lead product in solid tumors and launches a Phase II clinical study in pancreatic cancer January 7, 2014 ERYTECH Provides Business Update and Reports Financial Results for Full Year 2018 March 11, 2019 ERYTECH Partners with New York Blood Center for Red Blood Cell Supply and Research November 15, 2018
ERYTECH positions its lead product in solid tumors and launches a Phase II clinical study in pancreatic cancer January 7, 2014
